[PDF][PDF] Enhancing immune responses to tumor-associated antigens
JP Higgins, MB Bernstein, JW Hodge - Cancer biology & therapy, 2009 - Taylor & Francis
The goal of vaccine-based cancer immunotherapy is to induce a tumor-specific immune
response that ultimately reduces tumor burden. However, the immune system is often …
response that ultimately reduces tumor burden. However, the immune system is often …
COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells
ZL Li, SB Ye, LY OuYang, H Zhang, YS Chen… - …, 2015 - Taylor & Francis
The expansion of myeloid-derived suppressor cells (MDSCs) is a common feature of cancer,
but its biological roles and molecular mechanism remain unclear. Here, we investigated a …
but its biological roles and molecular mechanism remain unclear. Here, we investigated a …
The progress on genetic analysis of nasopharyngeal carcinoma
X Zhou, J Cui, V Macias… - … Journal of Genomics, 2007 - Wiley Online Library
Nasopharyngeal carcinoma (NPC) is a rare malignancy in most parts of the world, but is one
of the most common cancers in Southeast Asia. Both genetic and environmental factors …
of the most common cancers in Southeast Asia. Both genetic and environmental factors …
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
S Mizuarai, K Yamanaka, H Itadani, T Arai, T Nishibata… - Molecular cancer, 2009 - Springer
Background Wee1 is a tyrosine kinase regulating S-G2 cell cycle transition through the
inactivating phosphorylation of CDC2. The inhibition of Wee1 kinase by a selective small …
inactivating phosphorylation of CDC2. The inhibition of Wee1 kinase by a selective small …
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Nasopharyngeal carcinoma (NPC) is an Asian-prevalent head and neck cancer with high
invasiveness. Although several important risk factors for NPC development have been …
invasiveness. Although several important risk factors for NPC development have been …
Proline-dependent induction of apoptosis in oral squamous cell carcinoma (OSCC)—the effect of celecoxib
N Tołoczko-Iwaniuk, D Dziemiańczyk-Pakieła… - Cancers, 2020 - mdpi.com
Background: Oral squamous cell carcinoma remains a significant worldwide public health
challenge, associated with high morbidity and mortality. Treatment of this type of cancer …
challenge, associated with high morbidity and mortality. Treatment of this type of cancer …
Prognostic significance of expression of cyclooxygenase‐2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma
J Pan, T Tang, L Xu, JJ Lu, S Lin, S Qiu, G Chen… - Head & …, 2013 - Wiley Online Library
Background The association between expression of cyclooxygenase‐2 (COX‐2), vascular
endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), and the long …
endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), and the long …
Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles
Current treatment of advanced-stage nasopharyngeal carcinoma (NPC) is not satisfactory.
Targeted therapies offer hope for extending survival. Here, we developed simple, robust …
Targeted therapies offer hope for extending survival. Here, we developed simple, robust …
Clinical biomarkers of angiogenesis inhibition
AP Brown, DE Citrin, KA Camphausen - Cancer and Metastasis Reviews, 2008 - Springer
Introduction An expanding understanding of the importance of angiogenesis in oncology
and the development of numerous angiogenesis inhibitors are driving the search for …
and the development of numerous angiogenesis inhibitors are driving the search for …
Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
K Antoniou, M Malamas, AA Drosos - Expert opinion on …, 2007 - Taylor & Francis
NSAIDs are extensively used worldwide; nonetheless, they are associated with adverse
gastrointestinal (GI) effects. COX-2 inhibitors (coxibs) have been developed to reduce pain …
gastrointestinal (GI) effects. COX-2 inhibitors (coxibs) have been developed to reduce pain …